semaglutide revenue Market Size, Share & Trends Report, 2025-2035 Semaglutide Market Share, Size &

Both medications are a once weekly injection typically given in the abdomen, thigh, or upper arm Based upon your tolerance, goals, and response the medication dose will be increased on a monthly basis Benefits of Semaglutide and Tirzepatide Reduce risk of stroke, heart attack, death Reduces Hgb A1c and blood sugar Weight loss

Providers will recommend the best form based on your needs

Thousands of patients suing GLP-1 drugmakers Approximately 12% of American adults or more than 31 million people are currently using a GLP-1 drug, according to estimates from the nonpartisan health policy organization KFF

For others, they are disruptive enough to require dose adjustments or a slower treatment pace

For a more detailed breakdown, see the semaglutide to tirzepatide conversion chart